Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$3.52 - $9.59 $50,392 - $137,290
14,316 New
14,316 $53,000
Q3 2023

Nov 14, 2023

BUY
$8.23 - $13.93 $261,714 - $442,974
31,800 New
31,800 $265,000
Q4 2022

Feb 14, 2023

SELL
$5.67 - $11.2 $45,717 - $90,305
-8,063 Reduced 34.39%
15,382 $125,000
Q3 2022

Nov 14, 2022

BUY
$3.93 - $8.57 $92,138 - $200,923
23,445 New
23,445 $136,000
Q4 2018

Feb 14, 2019

SELL
$3.99 - $7.82 $94,551 - $185,310
-23,697 Closed
0 $0
Q1 2018

May 16, 2018

BUY
$2.05 - $3.23 $48,578 - $76,541
23,697 New
23,697 $49,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.